|
Mr Stromberg,
Thank you for your interesting assessment of the Prospectus; however,
it is clear that you are most suited for investment in the GE's &
GM's of today, and not the future.
You may not be aware, but a lot of companies actually start small.
Procyon is a small company, this is the ground floor. I
would suggest that you have not read many a penny stock prospectus,
as the terminology that brings you such grave concern is known as
boiler-plate, a very legal investment house CYA.
Please humor me whilst I enlighten you as to the two factors that
bring investors to biotech companies: 1) Motivation for profit,
but more importantly, 2) Social responsibility, the desire to assist
in the funding of a company that is not only "producing something",
but potentially rather saving somebody.
I wish I could live in your world where you feel that there are
no diseases for the company's development products. Someday, you
may not think that ANA's have no use when they are used
to prolong the life of a loved one.
Good luck my friend.
Makes lots of money, but please don't get sick,
Tim |
